Concepedia

<p>Feasibility and safety of neoadjuvant laparoscopic hyperthermic intraperitoneal chemotherapy in patients with advanced stage ovarian cancer: a single-center experience</p>

Tian Gao, Xiaoxin Huang, Wu-Yun Wang, Miao‐fang Wu, Zhongqiu Lin, Jing Li

Cancer Management and Research · 2019 · 13 citations · 33 references

DOIFull text

Open access

Abstract

NLHIPEC appears to be a feasible option for ovarian cancer patients who have a low likelihood of achieving optimal cytoreduction during PDS.

References

33

Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer

Deborah K. Armstrong, Brian N. Bundy, Lari Wenzel et al. · New England Journal of Medicine · 2006 · 2.6K citations · Full text

Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer

Ignace Vergote, Claes G. Tropé, Frédéric Amant et al. · New England Journal of Medicine · 2010 · 2.5K citations · Full text

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer

Willemien J. van Driel, Simone N. Koole, Karolina Sikorska et al. · New England Journal of Medicine · 2018 · 1.4K citations · Full text

Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial

Sean Kehoe, Jane Hook, Matthew Nankivell et al. · The Lancet · 2015 · 1.4K citations

, , +12

The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma

Mark F. Brady, Harrison Ball, Jonathan S. Berek · American Journal of Obstetrics and Gynecology · 1994 · 670 citations

, , +8